Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-02

Clinical Trial Update: Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the antipruritic effect of a topical combination of ketamine, amitriptyline, and lidocaine for pruritus was terminated, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical ketamine, amitriptyline, and lidocaine

Snippet

Sponsor: Gil Yosipovitch | Conditions: Pruritus | Phase 2 | Status: TERMINATED | Results posted: 2019-07-02